The curiously suspicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 37-41

  Praprotnik, Sonja ^a   Sodin Semrl, Snezna ^a   Tomsic, Matija ^a   Shoenfeld, Yehuda ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti DNA antibodies; Autoantibodies; Autoimmune diseases; Infections; Recovery; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CEFTAZIDIME; CIPROFLOXACIN; CLOXACILLIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; GANCICLOVIR; HEPARIN; HYDROXYCHLOROQUINE; IMIPENEM; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; VANCOMYCIN; VORICONAZOLE; WARFARIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CASE REPORT; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LABORATORY TEST; MICROBIAL IMMUNITY; MYCOSIS; PLASMAPHERESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT WITHDRAWAL; VIRUS INFECTION;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; FEMALE; HUMANS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 38049036446     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.002     Document Type: Article

References (48)

1. Cooper G.S., Dooley M.A., Treadwell E.L., Clair E.W.S., and Gilkeson G.S. Risk factors for development of systemic lupus erythematosus - allergies, infections, and family history. J Clin Epidemiol 55 (2002) 982-989
2. Bach J.-F. Infections and autoimmunity. J Autoimmun 25 (2005) 74-80
3. Blank M., Barzilai O., and Shoenfeld Y. Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32 (2007) 111-118
4. Lang K.S., Burow A., Kurrer M., Lang P.A., and Recher M. The role of the innate immune response in autoimmune disease. J Autoimmun 29 (2007) 206-212
5. Sundar K., Jacques S., Gottlieb P., Villars R., Benito M.-E., Taylor D.K., et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 23 (2004) 127-140
6. Severin M.C., Levy L., and Shoenfeld Y. Systemic lupus erythematosus and parvovirus B-19: causal coicidence or causative culprit?. Clin Rev Allergy Immunol 25 (2003) 41-48
7. Yazdanbakhsh M., Kremsner P.G., and van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
8. Vercelli D. Mechanisms of the hygiene hypothesis-molecular or otherwise. Curr Opin Immunol 18 (2006) 733-737
9. Liu A.H., and Leung D.Y.M. Renaissance of the hygiene hypothesis. J Allergy Clin Immunol 117 (2006) 1063-1066
10. Sotgiu S., Angius A., Embry A., Rosati G., and Musumeci S. Hygiene hypothesis: innate immunity, malaria and multiple sclerosis. Med Hypotheses (2007) PMID:17889443
11. Graham K.L., O'Donnell J.A., Tan Y., Sanders N., Carrington E.M., Allison J., et al. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol 81 (2007) 6446-6458
12. Chen M., Aosai F., Norose K., Mun H.-S., Ishikura H., Hiose S., et al. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand black × New Zealand white) F1 mice. Int Immunol 16 (2004) 937-946
13. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., and Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52 (2005) 1491-1503
14. Brett Finlay B., and McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124 (2006) 767-782
15. Lenert P.S. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res Ther 8 (2006) 203-213
16. Kitching A.R. More targeted treatments for lupus nephritis: is the future (nearly) here?. J Am Soc Nephrol 16 (2005) 3146-3148
17. Lit L.C., Wonq C.K., Li E.K., Tam L.S., Lam C.W., and Lo Y.M. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 34 (2007) 89-96
18. Dhar D., Roy S., and Das S. Translational control of the interferon regulatory factor 2 mRNA by IRES element. Nucleic Acids Res 35 (2007) 5409-5421
19. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
20. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27 (2006) 110-118
21. Andreoli L., Pregnolato F., Burlingame R., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
22. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
23. Carrick D.M., Chulada P., Donn R., Fabris M., McNicholl J., Whitworth W., et al. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J Autoimmun 26 (2006) 182-196
24. Fekete A., Soos L., Szekanecz Z., Szabo Z., Szodoray P., Barath S., et al. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun 29 (2007) 154-163
25. Foreman A.L., Van de Water J., Gougeon M.L., and Gershwin M.E. B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 6 (2007) 387-401
26. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6 (2007) 169-175
27. Gleicher N., Weiner R., and Vietzke M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J Autoimmun 27 (2006) 161-165
28. Holvast B., Huckriede A., Kallenberg C.G., and Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective?. Autoimmun Rev 6 (2007) 300-305
29. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
30. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
31. Lan R.Y., Mackay I.R., and Gershwin M.E. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 272-280
32. Mackay I., Leskovek N., and Rose N. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
33. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
34. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29 (2007) 287-294
35. Miesbach W., Asherson R.A., Cervera R., Shoenfeld Y., Gomez Puerta J., Bucciarelli S., et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev 6 (2006) 94-97
36. Nakanishi Y., Tsuneyama K., Fujimoto M., Thucydides L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
37. Papadimitraki E.D., Bertsias G.K., and Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29 (2007) 310-318
38. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
39. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
40. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
41. Schultz H. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev 6 (2007) 223-227
42. Schwartz N., Su L., Burkly L.C., Mackay M., Aranow C., Kollaros M., et al. Urinary TWEAK and the activity of lupus nephritis. J Autoimmun 27 (2006) 242-250
43. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
44. Stojanovich L., Zandman-Goddard G., Pavlovich S., and Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 6 (2007) 421-426
45. von Landenberg P., Lehmann H.W., and Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 6 (2007) 278-285
46. Williams Jr. R.C. Autoimmune disease etiology-a perplexing paradox or a turning leaf?. Autoimmun Rev 6 (2007) 204-208
47. Wu J.F., Yang Y.H., Wang L.C., Lee J.H., Shen E.Y., and Chiang B.L. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. J Autoimmun 27 (2006) 119-124
48. Zandman-Goddard G., Peeva E., and Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 6 (2007) 366-372